
We are a cell culture service company located in West Lebanon, NH.
|
|
|
Northwestern/ASTS/AST Increased Risk Consensus Conference
AST
Share
  
April 27, 2012, 9 a.m. - 4 p.m.
Crowne Plaza Chicago O'Hare
Registration deadline extended to April 16
The Agency for Healthcare Research and Quality has provided funding to conduct a consensus conference. The goals of this conference will be:
- To develop a consensus definition of donors at increased risk of transmission of HIV, HBV and HCV
- To define the optimal evaluation of living donors to mitigate against infectious disease transmission, with a focus on HIV, HBV and HCV
- To define the optimal timing, content and method of informed consent of candidates considering accepting an organ from a donor at increased risk of HIV, HBV and HCV transmission
- To develop consensus on the optimal evaluation of recipients of organs from donors at increased risk of HIV, HBV and HCV transmission
Your participation is strongly encouraged to ensure representation of the varied opinions of the entire transplant community. The deadline to register for the consensus conference has been extended to Monday, April 16.
To attend, please complete the registration form and submit with the registration fee. Please see the registration form for information on making your hotel reservations.
For more information, please visit Northwestern University's Website.
AST Conversations in Transplantation (PODCAST)
AST
Share
  
New interview available
Biovigilance and its Interface with Organ Transplantation
In this podcast, Dr. Marian Michaels, pediatric infectious diseases at Children's Hospital of Pittsburgh of UPMC-University of Pittsburgh, discusses with Dr. Emily Blumberg, professor of medicine, division of infectious diseases- Perelman School of Medicine, University of Pennsylvania, the nuances of Biovigilance and its impact on Organ Transplantation.
Listen to the Podcast
Listen to all AST Podcasts
Call for Abstracts!
AST
Share
  

CALL FOR ABSTRACTS!
Submit your Basic, Translational or Clinical abstract on:
Transformational Immunosuppression Strategies
or
Novel Immune Monitoring and Diagnostics
Abstract submission site: www.esot.org → Meetings
Program topics include:
- Optimizing Co-Stimulation Blockade
Individualized Immunosuppression
- Current Pipeline in Biotech and Pharma and Small Molecules in the Pipeline
- Challenging Medical Decisions
- The Unmet Needs: New Molecules for DGF and New Molecules for Fibrosis
- Controversies in Transplantation: What is currently considered optimal therapy and why? Is chronic rejection inevitable?
Abstract Submission Deadline: Monday, 16 July 2012 at 5:59 p.m. EDT
 |
Pfizer is proud to support the ARTS Grants Program - a competitive, independent, peer-reviewed program for investigators in the United States.*
To apply for research grants and learn more about the program, the PfizerARTS website (www.PfizerARTS.com) will open for submissions on March 1, 2012 and the deadline for submissions is April 30, 2012 at midnight.
*Program open to US investigators only.
|
|
 |
|
AST Asks You
How many professional societies are you currently a member of?
❍ 1
❍ 2
❍ 3
❍ 4
❍ 5 or more
Answer now!
|
|
|
|
 |
• Home Infusion • Specialty Infusion • Clinical Pharmacy • Infusion Nursing • PO Medications • Ongoing Monitoring and Education • Benefit Verification • Patient Support 24/7 • Community Involvement
For comprehensive services, call 877.974.4844 or 877.974.4845.
|
Estimates of early death, acute liver failure and long-term mortality among live liver donors
Gastroenterology
Share
  
Researchers sought to estimate the risk of perioperative mortality or acute liver failure for live liver donors in the United States and avoid selection or ascertainment biases and sample size limitations.
More
Machine that keeps blood pumping around stomach of dead donors saves organs that would once have been thrown away
The Daily Mail
Share
  
Transplant surgeons have made a breakthrough that could potentially lead to hundreds more patients receiving organ transplants. A team from Queen Elizabeth Hospital in Birmingham, West Midlands, U.K., say they have managed to save and use transplant organs that would have been previously discarded.
More
 |
Champion patient recliners work harder and last longer. Heavy duty steel frames and mechanisms stand up to the most rigorous use. Beautiful styling and a wide palette of colors and patterns make it feel right at home in any healthcare environment. MORE
|
Organ transplant solution contaminated with bacillus cereus bacteria
Global Post
Share
  
A global alert was issued recently after a solution used to transport most organs for transplant was found to be contaminated with bacteria. The U.K. Department of Health said there was "no evidence" of problems in patients who had recently had transplants but it was "working urgently" to find alternative products to use during the transportation of organs.
More
Triple organ transplant saves young girl with rare disorder
msnbc
Share
  
On Dec. 29, in an unprecedented multiple-organ transplant on a child, Angela Bushi received a liver, two kidneys and a pancreas, doctors said. Angela had been newly diagnosed with a rare, fatal genetic disorder called Wolcott-Rallison Syndrome. Only about 60 cases of the disorder — which causes infant-onset diabetes and liver failure, as well as bone fractures, intellectual impairment and frequent infections — have been reported. The operation — the first time a transplant has been used to treat the disorder — "might offer some hope for these children with this rare syndrome, that life can be prolonged, hopefully in a very meaningful way," Dr. Andreas Tzakis, transplant surgeon, told msnbc.com.
More
 |
• We are an FDA licensed manufacturer.
• We label peptides, monoclonal antibodies, reagents, chemical and proteins for cancer treatments.
• Our above products can be labeled with radioisotopes such as I-125, I-131, P32, Tc99m, Y90 and AC-225. • We have a multicurie isotope license and an animal facility.
|
Medical edge: Kidney transplant between twins
KAAL-TV
Share
  
Kidney transplants are often successful operations. Unless a patient gets an organ from an identical twin, medications are necessary so that the body doesn't reject the new organ. Doctors at the Mayo Clinic in Austin, Minn., are looking at ways to grow organs from a patient's own stem cells. It is called regenerative medicine and it offers hope for a solution to organ rejection.
More
iPod video at DMV helps sign up organ donors
MedPage Today
Share
  
A five-minute video shown on an iPod at the department of motor vehicles may help increase the number of organ donors, researchers found. Participants who viewed the video, which addresses some common concerns about organ donation, were more likely to agree to be a donor than those who did not see the video (84 percent versus 72 percent; OR 2.05, 95 percent CI 1.49 to 2.81), according to Dr. J. Daryl Thornton, MPH, of MetroHealth Medical Center in Cleveland, and colleagues.
More
|
|
|